The statements mentioned in this content have not been evaluated by the FDA, and are not intended to prevent, diagnosis, or treat any disease. Always work with your personal healthcare provider. Worldwide, cardiovascular disease is the number one cause of death with 17.9 million people dying annually from disordersRead
Plastic is ubiquitous in today’s environment, and we see negative repercussions on cardiovascular health. A recent New England Journal of Medicine article showed that patients with microplastics and nanoplastics (MNPs) detected in carotid plaques had higher risk of myocardial infarction, stroke, or death from any cause.
Apolipoprotein B (ApoB) is a crucial structural protein found in atherogenic lipoproteins, including low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and lipoprotein(a) [Lp(a)]. Unlike other lipid markers such as LDL-C, which measure cholesterol content, ApoB provides a direct count of the number of atherogenic lipoprotein particles, makingRead
Protecting endothelial function is central to a comprehensive cardiovascular care protocol—here’s how ubiquinol helps. With the number of deaths from cardiovascular diseases on the rise, heart health remains a growing concern for practitioners. Over the past three decades, cardiovascular-related deaths have been steadily increasing, and in 2021, heart diseaseRead
Advanced lipid testing goes beyond traditional cholesterol panels, providing detailed insights into cardiovascular risk factors like Lp(a), apoB, and LDL-P. Discover how these tests support risk stratification, personalized treatments, and improved patient outcomes.
Lipoprotein(a), abbreviated as LP(a), is a unique lipoprotein particle that has garnered increasing attention in recent years due to its significant role in cardiovascular health. As an emerging biomarker, LP(a) is now recognized as a crucial factor in assessing a patient’s risk for atherosclerosis, coronary artery disease (CAD), and otherRead
Addressing a genetic issue & supporting cardiovascular health naturally. Cardiovascular health for many only becomes a concern with age, unless familial factors or birth defects highlight it earlier in life. Yet it isn’t uncommon that a higher profile story splashes the news, which reminds us that it may be somethingRead
There’s no doubt that we need to drastically improve our health. The fact that 60 percent of Americans are taking some kind of prescription drug should set off alarms in everyone. Synthetic medicines typically create more problems than they claim to solve. They are “one track” solutions to problems thatRead
“Endothelial glycocalyx (eGCx) deterioration is considered an early step in the onset of basically all chronic vascular complications.” In this article, I want to share with you information regarding the glycocalyx (eGCx). This is an aspect of CV health/disease that I suspect not a lot of practitioners have knowledge aboutRead
The Hibiscus plant is well-known for its brightly colored flowers, ranging from white and yellow to pink and red. For centuries, traditional medicine practitioners have used many of the over 200 species of Hibiscus. You may be familiar with Hibiscus, known as “sour tea” in Iran, a delicious and refreshingRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
